Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice

被引：214

作者：

Dosenovic, Pia ^{[1
]}

von Boehmer, Lotta ^{[1
]}

Escolano, Amelia ^{[1
]}

Jardine, Joseph ^{[3
,10
,11
]}

Freund, Natalia T. ^{[1
]}

Gitlin, Alexander D. ^{[1
]}

McGuire, Andrew T. ^{[4
]}

Kulp, Daniel W. ^{[3
,10
,11
]}

Oliveira, Thiago ^{[1
]}

Scharf, Louise ^{[5
]}

Pietzsch, John ^{[1
]}

Gray, Matthew D. ^{[4
]}

Cupo, Albert ^{[6
]}

van Gils, Marit J. ^{[7
]}

Yao, Kai-Hui ^{[1
]}

Liu, Cassie ^{[1
]}

Gazumyan, Anna ^{[1
,2
]}

Seaman, Michael S. ^{[8
]}

Bjoerkman, Pamela J. ^{[2
,5
]}

Sanders, Rogier W. ^{[6
]}

Moore, John P. ^{[6
]}

Stamatatos, Leonidas ^{[4
,9
]}

Schief, William R. ^{[3
,10
,11
,12
]}

Nussenzweig, Michel C. ^{[1
,2
]}

机构：

[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA

[2] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA

[3] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA

[4] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA

[5] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA

[6] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA

[7] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands

[8] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA

[9] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA

[10] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA

[11] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA

[12] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA

来源：

CELL | 2015年 / 161卷 / 07期

基金：

欧洲研究理事会; 加拿大健康研究院; 瑞典研究理事会;

关键词：

B-CELL RECEPTORS; ENVELOPE TRIMER; SOMATIC HYPERMUTATION; VACCINE; VIRUS; GP120; SITE; RECOMBINATION; GLYCOPROTEIN; AFFINITY;

D O I：

10.1016/j.cell.2015.06.003

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A subset of individuals infected with HIV-1 develops broadly neutralizing antibodies (bNAbs) that can prevent infection, but it has not yet been possible to elicit these antibodies by immunization. To systematically explore how immunization might be tailored to produce them, we generated mice expressing the predicted germline or mature heavy chains of a potent bNAb to the CD4 binding site (CD4bs) on the HIV-1 envelope glycoprotein (Env). Immunogens specifically designed to activate B cells bearing germline antibodies are required to initiate immune responses, but they do not elicit bNAbs. In contrast, native-like Env trimers fail to activate B cells expressing germline antibodies but elicit bNAbs by selecting for a restricted group of light chains bearing specific somatic mutations that enhance neutralizing activity. The data suggest that vaccination to elicit anti-HIV-1 antibodies will require immunization with a succession of related immunogens.

引用

页码：1505 / 1515

页数：11

共 50 条

[31] Recent progress in broadly neutralizing antibodies to HIV
Sok, Devin
Burton, Dennis R.
NATURE IMMUNOLOGY, 2018, 19 (11) : 1179 - 1188
[32] Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
Wagh, Kshitij
Seaman, Michael S.
Zingg, Marshall
Fitzsimons, Tomas
Barouch, Dan H.
Burton, Dennis R.
Connore, Mark
Ho, David D.
Mascola, John R.
Nussenzweig, Michel C.
Ravetch, Jeffrey
Gautam, Rajeev
Martin, Malcolm A.
Montefiori, David C.
Korber, Bette
PLOS PATHOGENS, 2018, 14 (03)
[33] Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
McCoy, Laura E.
Rutten, Lucy
Frampton, Dan
Anderson, Ian
Granger, Luke
Bashford-Rogers, Rachael
Dekkers, Gillian
Strokappe, Nika M.
Seaman, Michael S.
Koh, Willie
Grippo, Vanina
Kliche, Alexander
Verrips, Theo
Kellam, Paul
Fassati, Ariberto
Weiss, Robin A.
PLOS PATHOGENS, 2014, 10 (12)
[34] Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time
Hake, Anna
Pfeifer, Nico
PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (10)
[35] Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals
Schaefer, Alison
Yang, Bing
Schroeder, Holly A.
Harit, Dimple
Humphry, Mike S.
Ravel, Jacques
Lai, Samuel K.
ACTA BIOMATERIALIA, 2023, 169 : 387 - 397
[36] Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics
Smith, Tara
Masciotra, Silvina
Luo, Wei
Sullivan, Vickie
Switzer, William M.
Johnson, Jeffrey A.
Heneine, Walid
AIDS, 2021, 35 (10) : 1561 - 1565
[37] Immunologic basis for long HCDR3s in broadly neutralizing antibodies against HIV-1
Yu, Lei
Guan, Yongjun
FRONTIERS IN IMMUNOLOGY, 2014, 5
[38] HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant
Simonich, Cassandra A.
Williams, Katherine L.
Verkerke, Hans P.
Williams, James A.
Nduati, Ruth
Lee, Kelly K.
Overbaugh, Julie
CELL, 2016, 166 (01) : 77 - 87
[39] Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development
Yuan, Tingting
Li, Jingjing
Zhang, Yu
Wang, Yanping
Streaker, Emily
Dimitrov, Dimiter S.
Zhang, Mei-Yun
VACCINE, 2011, 29 (40) : 6903 - 6910
[40] To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1
Griffith, Sarah A.
McCoy, Laura E.
FRONTIERS IN IMMUNOLOGY, 2021, 12

← 1 2 3 4 5 →